{"id":"W3137926322","doi":"10.1016/j.ygyno.2021.03.015","title":"Population exposure-efficacy and exposure-safety analyses for rucaparib in patients with recurrent ovarian carcinoma from Study 10 and ARIEL2","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; Centre Hospitalier de l’Université de Montréal; University Health Network","funders":"National Cancer Institute; Cancer Research UK; Clovis Oncology","keywords":"Medicine; Internal medicine; Cmax; Adverse effect; Gastroenterology; Aspartate transaminase; Population; Response Evaluation Criteria in Solid Tumors; Urology; Oncology; Alanine transaminase; Pharmacokinetics; Surgery; Progressive disease; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009887229,0.0009808957,0.002216987,0.0007325267,0.000373393,0.001419531,0.0009778221,0.001064967,0.002699246],"category_scores_gemma":[0.007858718,0.00066134,0.005957227,0.0009014325,0.0005158994,0.001082395,0.0008633281,0.003046982,0.0003609262],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009684007,"about_ca_system_score_gemma":0.00128435,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002260426,"about_ca_topic_score_gemma":0.004202551,"domain_scores_codex":[0.9946777,0.003020521,0.0002992261,0.0008827852,0.0006775718,0.0004422764],"domain_scores_gemma":[0.9931421,0.002904664,0.001482552,0.001531981,0.0004777531,0.0004609965],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5141148,0.002637788,0.3352446,0.0009763517,0.0758466,0.0005377563,0.0004233302,0.005225668,0.00885282,0.0006184276,0.004349411,0.0511724],"study_design_scores_gemma":[0.04015549,0.05306885,0.8458211,0.00008327093,0.04106376,0.000737301,0.0003561974,0.004413827,0.003563448,0.0009974265,0.009555977,0.0001833563],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904156,0.002140485,0.001098178,0.0001822588,0.00005086076,0.0002373383,0.004098121,0.00009370645,0.001683368],"genre_scores_gemma":[0.9932054,0.0003968474,0.0003846428,0.0002697289,0.00006509574,0.0001850381,0.004341694,0.00003753613,0.001113916],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009887229,"threshold_uncertainty_score":0.05228931,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05311737377274775,"score_gpt":0.3609906774511664,"score_spread":0.3078733036784187,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}